An ASNC Information Statement: Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis
Resource Type
Information Statements, Practice Points
Year Published
2022
Related Resources
Cases
PET Case: Atrial Septal Hypertrophy Masquerading as Potential Malignancy: Role of PET Imaging
Case summary: This case highlights the role of cardiac PET/CT in evaluation…
